43.5 F
Fort Worth
Thursday, October 29, 2020
Health Care Alcon acquries intraocular lens company PowerVision for $285M

Alcon acquries intraocular lens company PowerVision for $285M

Other News

A look at big issues on Supreme Court’s agenda

Some of the issues either already on the Supreme Court's docket when it begins its new session or likely to be before...

Wall Street posts solid gains after surge in corporate deals

By ALEX VEIGA and DAMIAN J. TROISE AP Business Writers Wall Street kicked off the week with a broad...

Tarrant County ranks low in work-from-home study by NAR

North Texas ranks pretty high in the “Work from Home” category, according to a just-released study by the National Association of Realtors....

Commentary: Universities and COVID-19: Charting turbulent times

Ray Perryman As the COVID-19 pandemic emerged this spring, college campuses across the United States swiftly sent students...

Fort Worth-based Alcon, the eye care division of Novartis, announced March 18 it has acquired PowerVision Inc., a privately-held, U.S.-based medical device development company focused on creating fluid-based intraocular lens implants.

Under the terms of the agreement, Alcon paid $285 million to PowerVision at closing with additional payments based on specified regulatory and commercial milestones starting in 2023. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating lens to cataract patients throughout the world.

Commercial availability of PowerVision’s IOL technology will be determined following significant additional development and clinical trials of the intraocular lens, according to an Alcon news release.

“As the industry leader in cataract surgery, we’re eager to accelerate development of this potentially breakthrough accommodating lens technology,” said Michael Onuscheck, president of Global Business and Innovation. “By treating cataracts and restoring natural, continuous range of vision, this intraocular lens may be the preferred IOL for cataract surgery patients who desire spectacle independence.”

Novartis announced in June it planned to spin off its eye care division, Alcon. The acquisition of PowerVision will make Alcon more attractive to investors, according to several analysts.

PowerVision’s lens design utilizes the eye’s natural accommodating response to transport fluid in the intraocular lens which is implanted in the eye’s capsular bag. While most presbyopia-correcting intraocular lenses use a multifocal design that distributes light between different focal points, PowerVision’s fluid-based design creates a continuously variable monofocal lens, utilizing the natural contraction of the eye’s muscles. This technology allows the patient to actively focus on objects, just as the natural crystalline lens does in a youthful eye, providing patients with a natural, continuous range of vision.

“We’re thrilled to officially join Alcon and its pioneering history of launching new innovation in the field of ophthalmology,” said Barry Cheskin, president and CEO and co-founder of PowerVision. “We look forward to bringing this innovative IOL technology to eye care providers and customers in the years ahead.”

Alcon is maintaining its 2023 financial outlook provided at the Capital Markets Days in the fourth quarter of 2018.

Latest News

FBI warns ransomware assault threatens US healthcare system

By FRANK BAJAK AP Technology WriterBOSTON (AP) — Federal agencies warned that cybercriminals are unleashing a wave of data-scrambling extortion attempts against...

Tarrant County reports 5 COVID deaths

Tarrant County Public Health on Wednesday, Oct. 28 reported five COVID-19 deaths.The deceased include two women from Fort Worth in their 70s,...

2020 Dennis K. Stone Award Winner

Dr. Hubert Zajicek is the 2020 Dennis K. Stone Award, presented annually by Bio North Texas to an individual who has...

Barrett swearing-in differs markedly from ‘superspreader’

By AAMER MADHANI and MARY CLARE JALONICK Associated Press WASHINGTON (AP) — This time they mostly wore masks.

Care N’ Care Health Plan adds Methodist Medical Group

Care N’ Care (HMO/PPO) Health Plan added Methodist Medical Group into its provider network, effective Nov. 1. The group currently employs 227...